
YHO-13351 free base
CAS No. 912288-64-3
YHO-13351 free base( YHO13351 free base | YHO 13351 free base )
Catalog No. M16546 CAS No. 912288-64-3
YHO-13351 is an orally available prodrug of YHO-13177, which can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 43 | Get Quote |
![]() ![]() |
5MG | 72 | Get Quote |
![]() ![]() |
10MG | 110 | Get Quote |
![]() ![]() |
25MG | 200 | Get Quote |
![]() ![]() |
50MG | 335 | Get Quote |
![]() ![]() |
100MG | 500 | Get Quote |
![]() ![]() |
500MG | 1098 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameYHO-13351 free base
-
NoteResearch use only, not for human use.
-
Brief DescriptionYHO-13351 is an orally available prodrug of YHO-13177, which can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.
-
DescriptionYHO-13351 is an orally available prodrug of YHO-13177, which can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo; YHO-13351 is rapidly converted into YHO-13177 after its oral or intravenous administration, significantly increases the survival time of mice inoculated with BCRP-transduced murine leukemia P388 cells and suppressed the tumor growth in an HCT116/BCRP xenograft model coadministration of irinotecan.
-
In Vitro——
-
In Vivo——
-
SynonymsYHO13351 free base | YHO 13351 free base
-
PathwayMembrane Transporter/Ion Channel
-
TargetBCRP
-
RecptorBCRP
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number912288-64-3
-
Formula Weight483.6229
-
Molecular FormulaC26H33N3O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 30 mg/mL
-
SMILESCCN(CC)CC(=O)OC1CCN(CC1)C2=CC=C(S2)C=C(C#N)C3=CC(=C(C=C3)OC)OC
-
Chemical NameGlycine, N,N-diethyl-, 1-[5-[(1Z)-2-cyano-2-(3,4-dimethoxyphenyl)ethenyl]-2-thienyl]-4-piperidinyl ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yamazaki R, et al. Mol Cancer Ther. 2011 Jul;10(7):1252-63.
molnova catalog



related products
-
CP-100356 hydrochlor...
CP-100356 hydrochloride is an orally active, low micromolar dual inhibitor of MDR1 (P-gp) and BCRP, a nucleotide-derived substrate analogue that inhibits MDR1-mediated Calcein-AM and BCRP-mediated Prazosin transporters.
-
Ko-143
A nontoxic analog of fungal toxin fumitremorgin C and potent, orally bioavailable inhibitor of BCRP (ABCG2) with EC90 of 26 nM.
-
YHO-13177
YHO-13177 is a acrylonitrile derivative and active form of YHO-13351 that can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.